Key facts
- Granted’s last known valuation is $68.0M (Jun 2024).
- It has raised $16.8M; the latest was Early Stage VC in Sep 2025.
- Notable investors include Forerunner Ventures, RRE Ventures, Habitat Partners, Factorial Capital, Red Sea Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Granted
- ·The full record, as it builds
Funding rounds
No funding rounds for Granted are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Granted
Developer of a healthcare insurance billing platform designed to manage claims and plan documents all in one place. The company's platform helps in securely linking with the insurance provider and in choosing benefits, bill checking, bill paying, and even bill negotiating, enabling patients to save time and money on healthcare and medical bills.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 22
- Website
- grantedhealth.com/
- Ownership
- Privately Held (backing)
Granted doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Granted shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Granted in its N-PORT filings yet. We sweep new filings monthly.